Severe course of rat bite-associated Weil's disease in a patient diagnosed with a new Leptospira-specific real-time quantitative LUX-PCR

References

1. Baranton G., Postic D. 2006; Trends in leptospirosis epidemiology in France. Sixty-six years of passive serological surveillance from 1920 to 2003. Int J Infect Dis 10:162–170 [CrossRef]
   [Google Scholar]
2. Bharti A. R., Nally J. E., Ricaldi J. N., Matthias M. A., Diaz M. M., Lovett M. A., Levett P. N., Gilman R. H., Willig M. R. & other authors; 2003; Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757–771 [CrossRef]
   [Google Scholar]
3. Brem S., Staak C., Schönberg A., Kopp H., Meyer P. 1999; Beitrag zur Leptospirenserologie des Hundes: Vergleich von MAR- und ELISA-Ergebnissen. Tierarztl Umsch 54:83–87
   [Google Scholar]
4. Cerny A., Ettlin D., Betschen K., Berchtold E., Hottinger S., Neftel K. A. 1992; Weil's disease after a rat bite. Eur J Med 1:315–316
   [Google Scholar]
5. Elliott S. P. 2007; Rat bite fever and Streptobacillus moniliformis . Clin Microbiol Rev 20:13–22 [CrossRef]
   [Google Scholar]
6. Gollop J. H., Katz A. R., Rudoy R. C., Sasaki D. M. 1993; Rat-bite leptospirosis. West J Med 159:76–77
   [Google Scholar]
7. Hanson L. E. 1982; Leptospirosis in domestic animals: the public health perspective. J Am Vet Med Assoc 181:1505–1509
   [Google Scholar]
8. Holk K., Nielsen S. V., Rønne T. 2000; Human leptospirosis in Denmark 1970–1996: an epidemiological and clinical study. Scand J Infect Dis 32:533–538 [CrossRef]
   [Google Scholar]
9. Jansen A., Schöneberg I., Frank C., Alpers K., Schneider T., Stark K. 2005; Leptospirosis in Germany, 1962–2003. Emerg Infect Dis 11:1048–1054 [CrossRef]
   [Google Scholar]
10. Jauréguiberry S., Roussel M., Brinchault-Rabin G., Gacouin A., Le Meur A., Arvieux C., Michelet C., Tattevin P. 2005; Clinical presentation of leptospirosis: a retrospective study of 34 patients admitted to a single institution in metropolitan France. Clin Microbiol Infect 11:391–394
    [Google Scholar]
11. Levett P. N., Morey R. E., Galloway R. L., Turner D. E., Steigerwalt A. G., Mayer L. W. 2005; Detection of pathogenic leptospires by real-time quantitative PCR. J Med Microbiol 54:45–49 [CrossRef]
    [Google Scholar]
12. Luzzi G. A., Milne L. M., Waitkins S. A. 1987; Rat-bite acquired leptospirosis. J Infect 15:57–60 [CrossRef]
    [Google Scholar]
13. Panaphut T., Domrongkitchaiporn S., Vibhagool A., Thinkamrop B., Susaengrat W. 2003; Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 36:1507–1513 [CrossRef]
    [Google Scholar]
14. Segura E. R., Ganoza C. A., Campos K., Ricaldi J. N., Torres S., Silva H., Céspedes M. J., Matthias M. A., Swancutt M. A. other authors 2005; Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 40:343–351 [CrossRef]
    [Google Scholar]
15. Smythe L. D., Smith I. L., Smith G. A., Dohnt M. F., Symonds M. L., Barnett L. J., McKay D. B. 2002; A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect Dis 2:13 [CrossRef]
    [Google Scholar]
16. Viriyakosol S., Matthias M. A., Swancutt M. A., Kirkland T. N., Vinetz J. M. 2006; Toll-like receptor 4 protects against lethal Leptospira interrogans serovar Icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun 74:887–895 [CrossRef]
    [Google Scholar]
17. WHO & ILS 2003 Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control Geneva: World Health Organization & International Leptospirosis Society;
    [Google Scholar]